Combining molecular and functional imaging in metastatic castration-resistant prostate cancer (mCRPC).

Authors

null

Vincenza Conteduca

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy

Vincenza Conteduca , Emanuela Scarpi , Daniel Wetterskog , Paola Caroli , Alessandro Romanel , Cristian Lolli , Anuradha Jayaram , Giorgia Gurioli , Nicole Brighi , Giulia Poti , Anna Wingate , Giuseppe Schepisi , Federica Matteucci , Giovanni Paganelli , Francesca Demichelis , Gerhardt Attard , Ugo De Giorgi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Advanced Disease

Track

Prostate Cancer - Advanced

Sub Track

Translational Research

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 141)

DOI

10.1200/JCO.2021.39.6_suppl.141

Abstract #

141

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Simon J. Crabb

First Author: Russell Kent Pachynski

Poster

2020 Genitourinary Cancers Symposium

FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC).

FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC).

First Author: Katherine A. Zukotynski